secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001437749-25-000930
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree appoints Leanne Kelly to board; launches strategy to acquire small biotechs with equity
--------------------------------------------------------------------------------

- Leanne Kelly appointed as independent director and Audit Committee chair effective Jan 8, 2025.
- CEO states new corporate strategy: use equity to acquire small biotechs with FDA-approved products to become revenue-generating.
- Company received Nasdaq deficiency notice Dec 4, 2024 for independent director/audit committee; expects Kelly's appointment to resolve.
- Kelly is currently CFO of GRI Bio, with over 20 years of public company experience in life sciences and accounting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774925000930/0001437749-25-000930-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774925000930/wint20250112_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-000930

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer